Relationship between p53 codon 72 polymorphism and susceptibility to sunburn and skin cancer

Journal of Investigative Dermatology

Volumn 119, Issue 1, 2002, Pages 84-90

  McGregor, Jane M ^a   Harwood, Catherine A ^a   Brooks, Louise ^a   Fisher, Sheila A ^a   Kelly, Deirdre A ^a   O'nions, Jenny ^a   Young, Antony R ^a   Surentheran, Thiru ^a   Breuer, Judith ^a   Millard, Thomas P ^a   Lewis, Cathryn M ^a   Leigh, Irene M ^a   Storey, Alan ^a   Crook, Timothy ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b LUDWIG INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

Author keywords

Human papillomavirus; Immunosuppression; Nonmelanoma skin cancer; Renal transplantation; Ultraviolet radiation

Indexed keywords

PROTEIN P53;

ALLELE; AMINO ACID SEQUENCE; BASAL CELL CARCINOMA; CANCER RISK; CANCER SUSCEPTIBILITY; CODON; CONFERENCE PAPER; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA POLYMORPHISM; ERYTHEMA; GENE MUTATION; GENETIC SUSCEPTIBILITY; HETEROZYGOSITY LOSS; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; IMMUNOCOMPETENCE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MELANOMA; PRIORITY JOURNAL; SIMULATION; SKIN CARCINOMA; SOLAR RADIATION; SQUAMOUS CELL CARCINOMA; SUNBURN;

EID: 18644380783     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.2002.01655.x     Document Type: Article

References (42)

1. Agorastos T, Lambropoulos AF, Constantinidis TC, Kotsis A, Bontis JN: p53 codon 72 polymorphism and risk of intra-epithelial and invasive cervical neoplasia in Greek women. Eur J Cancer Prev 9:113-118, 2000
2. Bastiaens MT, Struyk L, Tjong A, et al: Cutaneous squamous cell carcinoma and p53 codon 72 polymorphism: A need for screening? Mol Carcinog 30:56-61, 2001
3. Beckman G, Birgander R, Själander A, Saha N, Holmberg PA, Kivelä A, Beckman L: Is p53 polymorphism maintained by natural selection? Hum Hered 44:266-270, 1994
4. Bertorelle R, Chieco-Binchi L, Del Mistro A: Papillomaurus and p53 codon 72 polymorphism. Int J Cancer 82:616-617, 1999
5. Diffey BL, Farr PM: The normal range in diagnostic phototesting. Br J Dermatol 120:517-524, 1989
6. Dokianakis DN, Koumantaki E, Billiri K, Spandidos DA: p53 codon 72 polymorphism as a risk factor in the development of HPV-associated nonmelanoma skin cancers in immunocompetent hosts. Int J Mol Med 5:405-409, 2000
7. van Duin M, Snijders PJF, Vossen MTM, et al: Analysis of human papillomavirus type 16E6 variants in relation to p53 codon 72 polymorphism genotypes in cervical carcinogenesis. J Gen Virol 81:317-325, 2000
8. Fitzpatrick TB: The validity and practicality of sun-reactive skin types I through VI. Arch Dermatol 124:869-871, 1988
9. Harwood CA, Spink PJ, Surentheran T, et al: Degenerate and nested PCR: A highly sensitive and specific method for the detection of human papillomavirus infection in cutaneous warts. J Clin Microbiol 37:3545-3555, 1999
10. Harwood CA, Surentheran T, McGregor JM, Spink PJ, Leigh IM, Breuer J, Proby CM: Human papillomavirus infection and non-melanoma skin cancer in immunosuppressed and immunocompetent individuals. J Med Virol 61:289- 297, 2000
11. Helland A, Langerod A, Jonsen H, Olsen AO, Skovlund E, Borrensen-Dale AL: P53 polymorphism and risk of cervical cancer. Nature 396:530-531, 1998
12. Hildesheim A, Schiffman M, Brinton LA, et al: p53 polymorphism and risk of cervical cancer. Nature 396:531-532, 1998
13. Jackson S, Storey A: E6 proteins from diverse cutaneous HPV types inhibit apoptosis in response to UV damage. Oncogene 19:592-598, 2000
14. Jackson S, Harwood CA, Thomas M, Banks L, Storey A: Role of Bak in UV-induced apoptosis in skin cancer and abrogation by HPV E6 proteins. Genes Dev 14:3065-3073, 2000
15. Jones MH, Nakamura Y: Detection of loss of heterozygosity at the human TP53 locus using a dinucleotide repeat polymorphism. Genes Chromosomes Cancer 5:89-90, 1992
16. Josefsson AM, Magnusson PKE, Ylitalo N, Quarforth-Tubbin P, Ponten J, Adami HO, Gyllensten UB: P53 polymorphism and risk of cervical cancer. Nature 396:531, 1998
17. Kaelin WG: The emerging p53 gene family. J Natl Cancer Inst 91:594-598, 1999
18. Kawaguchi H, Ohno S, Araki K, et al: p53 polymorphism in human papillomavirus-associated esophageal cancer. Cancer Res 60:2753-2755, 2000
19. Kelly DA, Young AR, McGregor JM, Seed PT, Potten CS, Walker SL: Sensitivity to sunburn is associated with susceptibility to ultraviolet radiation-induced suppression of cutaneous cell-mediated immunity. J Exp Med 191:561-566, 2000
20. Klaes R, Ridder R, Scafer U, Benner A, Doeberitz MV: No evidence of p53 allele-specific predisposition in human papillomavirus-associated cervical cancer. J Mol Med 77:299-302, 1999
21. Lamb P, Crawford L: Characterisation of the human p53 gene. Mol Cell Biol 6:1379-1385, 1986
22. Lanham S, Campbell I, Watt P, Gornall R: p53 polymorphism and risk of cervical cancer. Lancet 352:1631, 1998
23. Makni H, Franco EL, Kaiano J, et al: p53 polymorphism in codon 72 and risk of human papillomavirus-induced cervical cancer: Effect of inter-laboratory variation. Int J Cancer 87:528-533, 2000
24. Marin MC, Jost CA, Brooks LA, et al: A common polymorphism acts as an intragenic modifier of mutant p53 behaviour. Nature Genet 25:47-54, 2000
25. Marshall SE, Bordea C, Wojnarowska F, Morris PJ, Welsh KI: P53 codon 72 polymorphism and susceptibility to skin cancer after renal transplantation. Transplantation 69:994-996, 2000
26. Matlashewski G, Tuck S, Pim D, Lamb P, Schneider J, Crawford L: Primary structure polymorphism at amino acid residue 72 of human p53. Mol Cell Biol 7:961-963, 1987
27. May P, May E: Twenty years of p53 research: Structural and functional aspects of the p53 protein. Oncogene 18:7621-7637, 1999
28. McGregor JM, Proby CM: Skin cancer in transplant recipients. Lancet 346:964-965, 1996
29. McGregor JM, Berkhout RM, Rozycka M, ter Schegget J, Bouwes Bavincke JN, Brooks L, Crook T: P53 mutations implicate sunlight in posttransplant skin cancer irrespective of human papillomavirus status. Oncogene 15:1727-1740, 1997
30. Minagichi T, Kanamori Y, Matsushima M, Yoshikawa H, Taketani Y, Nakamura Y: No evidence of correlation between polymorphism at codon 72 of p53 and risk of cervical cancer in Japanese patients with human papillomaurus 16/18 infection. Cancer Res 58:4585-4586, 1998
31. Nigro JM, Baker SJ, Preisinger AC, et al: Mutations in the p53 gene occur in diverse human tumour types. Nature 342:705-708, 1989
32. Oliphant AR, Wright EC, Swensen J, Gruis NA, Goldgar D, Skolnick MH: Dinucleotide repeat polymorphism at the D175514 locus. Nucleic Acids Res 19:4794, 1991
33. Proby C, Storey A, McGregor J, Leigh I: Does human papillomavirus infection play a role in non-melanoma skin cancer? Papillomavirus Rep 7:53-60, 1996
34. Rosenthal AN, Ryan A, Al-Jehani RM, Storey A, Harwood CA, Jacobs IJ: P53 codon 72 polymorphism and risk of cervical cancer in the UK. Lancet 352:871-872, 1998
35. Själander A, Birgander R, Kivelä A, Beckman G: p53 polymorphisms and haplotypes in different ethnic groups. Hum Hered 45:144-149, 1995
36. Soussi T, Caron DF, Mechali M, May P, Kress M: Cloning and characterization of a cDNA from Xenopus laevis coding for protein homologous to human and murine p53. Oncogene 1:71-78, 1987
37. Storey A, Thomas M, Kalita A, et al: Role of p53 polymorphism in the development of human papillomavirus-associated cancer. Nature 393:229-234, 1998
38. Thomas M, Kalita A, Labrecque S, Pim D, Banks L, Matlashewski G: Two polymorphic forms of wild type p53 differ biochemically and biologically. Mol Cell Biol 2:1092-1100, 1999
39. Venot C, Maratrat M, Dureuil C, Conseiller E, Bracco L, Debussche L: The requirement for the proline rich functional domain for mediation of apoptosis is correlated with specific PIG3 gene transactivation and with transcriptional repression. EMBO J 17:4668-4679, 1998
40. Walker KK, Levine AJ: Identification of a novel p53 functional domain that is necessary for efficient growth suppression. Proc Natl Acad Sci USA 93:15335-15340, 1996
41. Zehbe I, Voglino G, Wilander E, Genta F, Tommasino M: Codon 72 polymorphism of p53 and its association with cervical cancer. Lancet 354:218-219, 1999
42. Zhu J, Jiang J, Zhou W, Zhu K, Chen X: Differential regulation of cellular target genes by p53 devoid of the PXXP motifs with impaired apoptotic activity. Oncogene 18:2149-2155, 1999